Global Voltaren Market Research Report 2021
Table of Content
1 Voltaren Market Overview
- 1.1 Product Overview and Scope of Voltaren
- 1.2 Voltaren Segment by Type
- 1.2.1 Global Voltaren Sales Growth Rate Comparison by Type (2021-2027)
- 1.2.2 Tablet
- 1.2.3 Injection
- 1.2.4 Gel
- 1.2.5 Spray
- 1.2.6 Capsule
- 1.3 Voltaren Segment by Application
- 1.3.1 Voltaren Sales Comparison by Application: (2021-2027)
- 1.3.2 Elderly
- 1.3.3 Adults
- 1.4 Global Voltaren Market Size Estimates and Forecasts
- 1.4.1 Global Voltaren Revenue 2016-2027
- 1.4.2 Global Voltaren Sales 2016-2027
- 1.4.3 Voltaren Market Size by Region: 2016 Versus 2021 Versus 2027
2 Voltaren Market Competition by Manufacturers
- 2.1 Global Voltaren Sales Market Share by Manufacturers (2016-2021)
- 2.2 Global Voltaren Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Global Voltaren Average Price by Manufacturers (2016-2021)
- 2.4 Manufacturers Voltaren Manufacturing Sites, Area Served, Product Type
- 2.5 Voltaren Market Competitive Situation and Trends
- 2.5.1 Voltaren Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Voltaren Players Market Share by Revenue
- 2.5.3 Global Voltaren Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Voltaren Retrospective Market Scenario by Region
- 3.1 Global Voltaren Retrospective Market Scenario in Revenue by Region: 2016-2021
- 3.2 Global Voltaren Retrospective Market Scenario in Sales by Region: 2016-2021
- 3.3 North America Voltaren Market Facts & Figures by Country
- 3.3.1 North America Voltaren Sales by Country
- 3.3.2 North America Voltaren Revenue by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Voltaren Market Facts & Figures by Country
- 3.4.1 Europe Voltaren Sales by Country
- 3.4.2 Europe Voltaren Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Voltaren Market Facts & Figures by Region
- 3.5.1 Asia Pacific Voltaren Sales by Region
- 3.5.2 Asia Pacific Voltaren Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Voltaren Market Facts & Figures by Country
- 3.6.1 Latin America Voltaren Sales by Country
- 3.6.2 Latin America Voltaren Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Voltaren Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Voltaren Sales by Country
- 3.7.2 Middle East and Africa Voltaren Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global Voltaren Historic Market Analysis by Type
- 4.1 Global Voltaren Sales Market Share by Type (2016-2021)
- 4.2 Global Voltaren Revenue Market Share by Type (2016-2021)
- 4.3 Global Voltaren Price by Type (2016-2021)
5 Global Voltaren Historic Market Analysis by Application
- 5.1 Global Voltaren Sales Market Share by Application (2016-2021)
- 5.2 Global Voltaren Revenue Market Share by Application (2016-2021)
- 5.3 Global Voltaren Price by Application (2016-2021)
6 Key Companies Profiled
- 6.1 Novartis
- 6.1.1 Novartis Corporation Information
- 6.1.2 Novartis Description and Business Overview
- 6.1.3 Novartis Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.1.4 Novartis Product Portfolio
- 6.1.5 Novartis Recent Developments/Updates
- 6.2 GSK
- 6.2.1 GSK Corporation Information
- 6.2.2 GSK Description and Business Overview
- 6.2.3 GSK Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.2.4 GSK Product Portfolio
- 6.2.5 GSK Recent Developments/Updates
- 6.3 Enovachem Pharmaceuticals
- 6.3.1 Enovachem Pharmaceuticals Corporation Information
- 6.3.2 Enovachem Pharmaceuticals Description and Business Overview
- 6.3.3 Enovachem Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.3.4 Enovachem Pharmaceuticals Product Portfolio
- 6.3.5 Enovachem Pharmaceuticals Recent Developments/Updates
- 6.4 Jewim Pharmaceutical
- 6.4.1 Jewim Pharmaceutical Corporation Information
- 6.4.2 Jewim Pharmaceutical Description and Business Overview
- 6.4.3 Jewim Pharmaceutical Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Jewim Pharmaceutical Product Portfolio
- 6.4.5 Jewim Pharmaceutical Recent Developments/Updates
- 6.5 Hainan Quanxing Pharmaceutical
- 6.5.1 Hainan Quanxing Pharmaceutical Corporation Information
- 6.5.2 Hainan Quanxing Pharmaceutical Description and Business Overview
- 6.5.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.5.4 Hainan Quanxing Pharmaceutical Product Portfolio
- 6.5.5 Hainan Quanxing Pharmaceutical Recent Developments/Updates
- 6.6 Supor South Ocean
- 6.6.1 Supor South Ocean Corporation Information
- 6.6.2 Supor South Ocean Description and Business Overview
- 6.6.3 Supor South Ocean Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.6.4 Supor South Ocean Product Portfolio
- 6.6.5 Supor South Ocean Recent Developments/Updates
- 6.7 Endo Pharmaceuticals
- 6.6.1 Endo Pharmaceuticals Corporation Information
- 6.6.2 Endo Pharmaceuticals Description and Business Overview
- 6.6.3 Endo Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Endo Pharmaceuticals Product Portfolio
- 6.7.5 Endo Pharmaceuticals Recent Developments/Updates
- 6.8 Iroko Pharmaceuticals
- 6.8.1 Iroko Pharmaceuticals Corporation Information
- 6.8.2 Iroko Pharmaceuticals Description and Business Overview
- 6.8.3 Iroko Pharmaceuticals Voltaren Sales, Revenue and Gross Margin (2016-2021)
- 6.8.4 Iroko Pharmaceuticals Product Portfolio
- 6.8.5 Iroko Pharmaceuticals Recent Developments/Updates
7 Voltaren Manufacturing Cost Analysis
- 7.1 Voltaren Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Voltaren
- 7.4 Voltaren Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Voltaren Distributors List
- 8.3 Voltaren Customers
9 Voltaren Market Dynamics
- 9.1 Voltaren Industry Trends
- 9.2 Voltaren Growth Drivers
- 9.3 Voltaren Market Challenges
- 9.4 Voltaren Market Restraints
10 Global Market Forecast
- 10.1 Voltaren Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Voltaren by Type (2022-2027)
- 10.1.2 Global Forecasted Revenue of Voltaren by Type (2022-2027)
- 10.2 Voltaren Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Voltaren by Application (2022-2027)
- 10.2.2 Global Forecasted Revenue of Voltaren by Application (2022-2027)
- 10.3 Voltaren Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Voltaren by Region (2022-2027)
- 10.3.2 Global Forecasted Revenue of Voltaren by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Description
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tablet
Injection
Gel
Spray
Capsule
Segment by Application
Elderly
Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
GSK
Enovachem Pharmaceuticals
Jewim Pharmaceutical
Hainan Quanxing Pharmaceutical
Supor South Ocean
Endo Pharmaceuticals
Iroko Pharmaceuticals